Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Add-on valacyclovir treatment for psychosis symptoms in schizophrenia or bipolar disorder
2006-006940-69Phase 2Terminated
- Sponsor
- Skåne University Hospital
- Start
- Feb 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia and bipolar disorder (BD) comparing Valtrex add-on with Placebo add-on (2 arms). Primary endpoint: Change in total PANSS score from baseline to week 18. Started Feb 2007; status: terminated.
02
Drugs
valaciclovir
03
Conditions
schizophreniabipolar disorder (BD)
Beyond the preview
Go deeper on 2006-006940-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006940-69.